Julian C. Van Capelleveen
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Genetic variants in SUSD2 are associated with the risk of ischemic heart disease.
Journal: Journal of clinical lipidology
Published: November 24, 2019
Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study.
Journal: Journal of clinical lipidology
Published: March 01, 2018
Naturally Occurring Variants in LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Affect HDL (High-Density Lipoprotein) Metabolism Through ABCA1 (ATP-Binding Cassette A1) and SR-B1 (Scavenger Receptor Class B Type 1) in Humans.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: September 25, 2017
Association of High-Density Lipoprotein-Cholesterol Versus Apolipoprotein A-I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer-Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study.
Journal: Journal of the American Heart Association
Published: August 05, 2017
ABCA8 Regulates Cholesterol Efflux and High-Density Lipoprotein Cholesterol Levels.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: April 25, 2017
Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: January 11, 2017
Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials.
Journal: Lancet (London, England)
Published: September 26, 2016
Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease.
Journal: Journal of the American College of Cardiology
Published: June 20, 2016
Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses.
Journal: Journal of clinical lipidology
Published: March 24, 2016
Arterial and Cellular Inflammation in Patients with CKD.
Journal: Journal of the American Society of Nephrology : JASN
Published: March 17, 2016
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.
Journal: The New England journal of medicine
Published: March 03, 2016
Last Updated: 09/26/2026